Toxicity Linked to Longer Survival in Patients With NSCLC :

A new cohort study shows that some immune-related adverse events are linked to longer survival in patients with NSCLC treated with immunotherapy.

Related Keywords

Vishal Navani , Pierre Olivier Gaudreau , University Of Calgary , Alberta Health Services , Queen University In Ontario , Medscape Medical , Brimming Immune , Goldilock Side , Medscape Medical News , Non Small Cell Lung Cancer , Nsclc , Lung Cancer , Ung Carcinoma , Ancer Of The Lung , Canada , Biologic Therapy , Iologics , Toxicology , Toxicity , Poisoning , Toxins , Cancer , Alignant Neoplasia , Arcinoma , Alignant Neoplasm , Small Cell Lung Cancer , At Cell Lung Cancer , Clc , Immunotherapy , Skin Cancer , Alignant Skin Neoplasm , Adverse Effects , Side Effects , Lung , Patient Safety ,